chr17-50346285-C-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 2P and 10B. PM2BP4_StrongBP6_ModerateBS1

The NM_022167.4(XYLT2):​c.135+10C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000358 in 1,094,630 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00012 ( 1 hom. )

Consequence

XYLT2
NM_022167.4 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:2

Conservation

PhyloP100: 1.10
Variant links:
Genes affected
XYLT2 (HGNC:15517): (xylosyltransferase 2) The protein encoded by this gene is an isoform of xylosyltransferase, which belongs to a family of glycosyltransferases. This enzyme transfers xylose from UDP-xylose to specific serine residues of the core protein and initiates the biosynthesis of glycosaminoglycan chains in proteoglycans including chondroitin sulfate, heparan sulfate, heparin and dermatan sulfate. The enzyme activity, which is increased in scleroderma patients, is a diagnostic marker for the determination of sclerotic activity in systemic sclerosis. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 17-50346285-C-A is Benign according to our data. Variant chr17-50346285-C-A is described in ClinVar as [Benign]. Clinvar id is 709317.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0019 (281/147802) while in subpopulation AFR AF= 0.00642 (264/41128). AF 95% confidence interval is 0.00578. There are 0 homozygotes in gnomad4. There are 124 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
XYLT2NM_022167.4 linkuse as main transcriptc.135+10C>A intron_variant ENST00000017003.7
XYLT2NR_110010.2 linkuse as main transcriptn.150+10C>A intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
XYLT2ENST00000017003.7 linkuse as main transcriptc.135+10C>A intron_variant 1 NM_022167.4 P1Q9H1B5-1
XYLT2ENST00000376550.7 linkuse as main transcriptc.135+10C>A intron_variant, NMD_transcript_variant 1
XYLT2ENST00000507602.5 linkuse as main transcriptc.135+10C>A intron_variant 2
XYLT2ENST00000509778.1 linkuse as main transcriptc.90+55C>A intron_variant 3

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
270
AN:
147694
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00617
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000807
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000302
Gnomad OTH
AF:
0.00147
GnomAD3 exomes
AF:
0.000343
AC:
9
AN:
26258
Hom.:
0
AF XY:
0.000182
AC XY:
3
AN XY:
16504
show subpopulations
Gnomad AFR exome
AF:
0.0101
Gnomad AMR exome
AF:
0.00130
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00148
GnomAD4 exome
AF:
0.000117
AC:
111
AN:
946828
Hom.:
1
Cov.:
30
AF XY:
0.000113
AC XY:
51
AN XY:
452430
show subpopulations
Gnomad4 AFR exome
AF:
0.00527
Gnomad4 AMR exome
AF:
0.000194
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000121
Gnomad4 OTH exome
AF:
0.000460
GnomAD4 genome
AF:
0.00190
AC:
281
AN:
147802
Hom.:
0
Cov.:
32
AF XY:
0.00172
AC XY:
124
AN XY:
71978
show subpopulations
Gnomad4 AFR
AF:
0.00642
Gnomad4 AMR
AF:
0.000806
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000302
Gnomad4 OTH
AF:
0.00146
Alfa
AF:
0.00118
Hom.:
0

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 15, 2023- -
XYLT2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJun 03, 2024This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.72
CADD
Benign
9.8
DANN
Benign
0.70
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs374252074; hg19: chr17-48423646; API